Plasma resistin levels in asthmatics as a marker of disease state

Jeffrey LaRochelle*, John Freiler, John Dice, Larry Hagan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


Background. Resistin is a protein produced by adipoctyes and circulating macrophages that has been found to be associated with inflammatory states. Objective. To determine the levels of resistin in relation to asthma disease state and severity, we investigated a cohort of adult patients with asthma. Methods. A cohort of moderate to severe persistent asthma patients and control patients were recruited and underwent fasting labs to evaluate levels of serum glucose, C-reactive protein (CRP), and resistin. Results. No significant differences were found between the control and asthma group with respect to serum CRP at 0.78 ± 0.60 mg/dL and 0.48 ± 0.60 mg/dL, (p < 0.36) or glucose at 92.2 ± 11.9 mg/dL and 89.5 ± 7.2 mg/dL, (p < 0.084), respectively (mean ± SD). However, plasma resistin levels were found to be significantly elevated in asthma patients, 186 ng/mL (95%CI 169-202) compared with control patients 121 ng/mL (95%CI 90.4-151), (p < 0.005). Conclusions. Patients with asthma were found to have higher levels of resistin, and resistin levels were increased with disease severity in the asthma cohort.

Original languageEnglish
Pages (from-to)509-513
Number of pages5
JournalJournal of Asthma
Issue number7
StatePublished - Sep 2007
Externally publishedYes


  • Asthma
  • CRP
  • Diabetes
  • FIZZ
  • Resistin


Dive into the research topics of 'Plasma resistin levels in asthmatics as a marker of disease state'. Together they form a unique fingerprint.

Cite this